Arnold Library

Genetic Engineering of T-Cells to Benefit Anti-Tumor Immunotherapy

Schoenborn, Jamie (2012) Genetic Engineering of T-Cells to Benefit Anti-Tumor Immunotherapy. Science Spotlight, 2 (3).

[img]
Preview
Text
Genetic Engineering of T-Cells to Benefit Anti-Tumor Immunotherapy.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (306Kb) | Preview
Article URL: http://www.bloodjournal.org/content/119/17/3940
Item Type: Article
Additional Information: Till BG, Jensen MC, Wang J, Qian X, Gopal AK, Maloney DG, Lindgren CG, Lin Y, Pagel JM, Budde LE, Rautitschek A, Forman SJ, Greenberg PD, Riddell SR, Press OW. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood. DOI: 10.1182/blood-2011-10-387969.
Collections: Science Spotlight
Depositing User: Ben Abraham
Date Deposited: 10 Apr 2015 22:56
Last Modified: 10 Apr 2015 22:56
URI: http://authors.fhcrc.org/id/eprint/971

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy